Posts Tagged ‘birth control’
Continuing Contraception Care After Trump’s Orders
In light of recent actions over the last two weeks with our new administration, I wanted to provide updates and guidance to my pharmacist peers regarding reproductive health care. On…
Read MoreFounder Reflections on 2023
As I reflect on this past year, 2023 finally brought us some wins in reproductive health. And I personally had the opportunity to contribute to landmark steps forward. ⭐️ The…
Read MoreOver-the-Counter Birth Control Pills: FDA Considering HRA Pharma’s Opill
Why Over-the-Counter Birth Control? Oral contraceptives have been around since 1960, and their risks and safety profiles have been well-studied throughout the years. According to the Guttmacher Institute, unplanned pregnancies…
Read MoreUpdated Report on State Policy Efforts to Expand Access to Contraception in Pharmacies
Download free 22-page report describing the current landscape of direct access to contraception in pharmacies, state policy approaches and experiences, as well as implementation.
Read MoreLevonorgestrel Intrauterine Device for Emergency Contraception
A new research study evaluates levonorgestrel IUD for emergency contraception
Read MoreMeet Phexxi – A New Non-Hormonal Contraceptive Gel
About the Product Lactic acid, citric acid, and potassium bitartrate (Phexxi, Evofem Biosciences) is a prescription combination, non-hormonal contraceptive gel approved by the FDA in May 2020. The vaginal gel…
Read MoreContraception During COVID-19: Pharmacy Best Practices
Pharmacists should not allow postponed or cancelled appointments to keep patients from accessing birth control. It’s important that patients understand how their pharmacy can continue to meet their contraceptive needs…
Read MoreClinical Considerations for Contraception During COVID: Extended Duration of IUDs and Implants
During the COVID-19 pandemic and beyond, patients may desire a contactless method of contraception. The subcutaneous (SQ) formulation of depot medroxyprogesterone acetate (DMPA), Depo-SubQ Provera, is an important option to offer patients. This may be of particular interest among patients who currently come in to the pharmacy or go to a clinic for their intramuscular (IM) injection.
Read More5 Pearls from the 2020 States Forum on Pharmacist Birth Control Services
The second annual States Forum on Pharmacist Birth Control Services recently was held by the Birth Control Pharmacist project in partnership with the National Alliance of State Pharmacy Associations (NASPA).…
Read MoreClinical Considerations for Contraception During COVID: Patient Self-Administration
During the COVID-19 pandemic and beyond, patients may desire a contactless method of contraception. The subcutaneous (SQ) formulation of depot medroxyprogesterone acetate (DMPA), Depo-SubQ Provera, is an important option to offer patients. This may be of particular interest among patients who currently come in to the pharmacy or go to a clinic for their intramuscular (IM) injection.
Read More